Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Guangdong Association of Clinical Trials
Guangdong Association of Clinical Trials
Sichuan University
Alliance for Clinical Trials in Oncology
National Cancer Institute, Naples
Shanghai Henlius Biotech
Jiangsu HengRui Medicine Co., Ltd.
Sun Yat-sen University
Beijing Haidian Hospital
Guangzhou Institute of Respiratory Disease
Fuzhou General Hospital
Taizhou HoudeAoke Biomedical Co., Ltd.
Sun Yat-sen University
Shanghai Pulmonary Hospital, Shanghai, China
ChineseAMS
Zhejiang Cancer Hospital
Henan Cancer Hospital
Taizhou Hospital
Samsung Medical Center
Guizhou Medical University
Zhejiang Cancer Hospital
The First Affiliated Hospital of Guangzhou Medical University
Fudan University
Third Military Medical University
Sichuan Cancer Hospital and Research Institute
Guangdong Association of Clinical Trials
University Hospital, Angers
Third Military Medical University
Peking University Cancer Hospital & Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Swami Rama Cancer Hospital and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alaunos Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Charite University, Berlin, Germany